All the processes regarding concerned drug are performed on these three batches.
After checking the results the average of results from these batches is taken and data
will be compiled. This process results in formation of various documents like SOPs for
machines, record books, etc. After validation batches, the large-scale production of
For implementing efficient documentation practices, here is a suggestion which
mentions the areas required for GMP document implementation. These below
mentioned areas provide only guidance and should not be treated as maximum criteria
for documentation. Any other document not on the list will be included if helps in
improving the quality of products.
i. Design and development reports
iii. Operational procedures/techniques/methods, out of specifications (OOS), out
Fig. 2.5: Stepwise flow of products from small-scale batches to full-scale batches
General Considerations and Pilot-Plant Considerations for Different Dosage Forms 23
iv. User requirement specifications and utilities like water systems, HVAC, AHU,
v. Dossiers and Drug Master Files for regulated markets
vi. Man, materials, machines, methods, maintenance, manufacturing operations and
vii. Cleaning and calibration records and reports
viii. Containers and closures analysis report, contamination and change control,
ix. Monitoring, master formula, manuals (quality, safety and environment), medical
x. Engineering control and practices
xii. New products and substances
xv. SOPs, supplier qualification, specifications and standard test procedures
xvi. Site master file (quality assurance)
xvii. Stability studies reports, quality risk management report
xviii.Validation reports, qualification reports, analytical method transfer reports
xix. Notices, circulars, amendments, complaints details, entry–exit details, trend
xx. Safety practices, sanitation, storage, self-inspection, standardization,
xxi. Documents mentioning roles and responsibilities of personnel working at the
facility with their qualification and other details.
1. Describe pilot-plant scale-up consideration for solids in detail.
2. Describe pilot-plant scale-up considerations for semisolids and oral-liquids in detail.
No comments:
Post a Comment
اكتب تعليق حول الموضوع